NCT00798278

Brief Summary

A great controversy exists about which is the best method to perform the evacuation of the collection. The purpose of this study is to evaluate which is the best initial treatment to drain complicated parapneumonic empyema (stages II and III) in children: the present study raises a hypothesis of equivalence between both arms of treatment (chest drainage plus intrapleural urokinase or videothoracoscopic debridement).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2008

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 25, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 26, 2008

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
Last Updated

October 28, 2010

Status Verified

November 1, 2008

Enrollment Period

2.2 years

First QC Date

November 25, 2008

Last Update Submit

October 27, 2010

Conditions

Keywords

EmpyemaUrokinaseThoracoscopicChildhood

Outcome Measures

Primary Outcomes (1)

  • duration of the hospital stay after the treatment

    3 months

Secondary Outcomes (4)

  • complications of the treatment and complications of the disease

    3 months

  • total duration of the hospital stay

    3 months

  • number of days carrying the chest drain

    3 months

  • duration of the fever once the empyema has been drained

    3 months

Study Arms (2)

Urokinase

EXPERIMENTAL

urokinase infusion for 3 days

Drug: Urokinase

Thoracoscopic

ACTIVE COMPARATOR

Video-Assisted Thoracoscopic

Procedure: Video-Assisted Thoracoscopic

Interventions

Chest tube with intrapleural urokinase infusion for 3 days

Urokinase

Video-Assisted Thoracoscopic decortication

Thoracoscopic

Eligibility Criteria

Age1 Year - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients less than 15 years of age with pneumonia and persistent fever, and complicated parapneumonic empyema (septation or loculation seen on ultrasound or Rx thorax)stages II and III requiring an intervention to drain

You may not qualify if:

  • Existing contraindications or other previous conditions, hypertension, pneumothorax

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

University Hospital Vall d'Hebron

Barcelona, Barcelona, 08035, Spain

Location

Hospital de Donostia

San Sebastián, Donostia, 20014, Spain

Location

Hospital Gregorio Marañón

Madrid, Madrid, Spain

Location

Hospital Infantil La Paz

Madrid, Madrid, Spain

Location

Hospital Universitario 12 de Octubre

Madrid, Madrid, Spain

Location

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, Spain

Location

MeSH Terms

Conditions

EmpyemaPneumonia

Interventions

Urokinase-Type Plasminogen ActivatorThoracic Surgery, Video-Assisted

Condition Hierarchy (Ancestors)

SuppurationInfectionsInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Serine EndopeptidasesEndopeptidasesPeptide HydrolasesHydrolasesEnzymesEnzymes and CoenzymesSerine ProteasesPlasminogen ActivatorsBlood Coagulation FactorsBlood ProteinsProteinsAmino Acids, Peptides, and ProteinsThoracoscopyEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisVideo-Assisted SurgeryMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical Procedures

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 25, 2008

First Posted

November 26, 2008

Study Start

July 1, 2008

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

October 28, 2010

Record last verified: 2008-11

Locations